Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 180.13M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 173.90M | $ -527.00K | $ -467.00K | $ -405.00K | $ -471.00K |
| Operating Income | $ -497.88M | $ -380.50M | $ -293.57M | $ -242.48M | $ -206.67M |
| EBITDA | $ -450.13M | $ -379.97M | $ -293.10M | $ -242.08M | $ -206.20M |
| Net Income | $ -465.89M | $ -373.63M | $ -299.31M | $ -241.08M | $ -197.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 926.25M | $ 634.13M | $ 358.77M | $ 270.35M | $ 284.15M |
| Total Assets | $ 1.04B | $ 640.55M | $ 362.57M | $ 273.33M | $ 287.00M |
| Total Debt | $ 983.00K | $ 117.19M | $ 49.89M | $ 797.00K | $ 786.00K |
| Net Debt | $ -99.04M | $ 17.28M | $ -281.66M | $ -35.47M | $ -53.22M |
| Total Liabilities | $ 287.86M | $ 235.21M | $ 165.18M | $ 77.22M | $ 47.02M |
| Stockholders' Equity | $ 754.38M | $ 405.33M | $ 197.39M | $ 196.11M | $ 239.97M |
| Cash Flow | |||||
| Free Cash Flow | $ -457.03M | $ -325.71M | $ -225.07M | $ -184.13M | $ -157.90M |
| Operating Cash Flow | $ -455.57M | $ -324.23M | $ -224.86M | $ -183.92M | $ -157.56M |
| Investing Cash Flow | $ -274.39M | $ -502.52M | $ 206.69M | $ -5.05M | $ 159.78M |
| Financing Cash Flow | $ 735.06M | $ 595.12M | $ 313.45M | $ 171.24M | $ 5.09M |